Scholar Inbox

Scholar Inbox is a personal paper recommender which enables researchers to stay up-to-date with the most relevant progress in their field based on their personal research interests. Scholar Inbox is free of charge and daily indexes all of arXiv, bioRxiv, medRxiv and ChemRxiv as well as several open access proceedings in computer science. Register today and never miss a beat again!

Preprint sites bioRxiv and medRxiv launch new era of independence

The popular repositories, on which life scientists post research before peer review, will be managed by a new organization called openRxiv.

Preprint sites bioRxiv and medRxiv launch new era of independence

The popular repositories, on which life scientists post research before peer review, will be managed by a new organization called openRxiv.

Introducing openRxiv: a new independent home for preprint sharing in the life sciences - openRxiv

We’re thrilled to announce the launch of openRxiv as an independent nonprofit to oversee bioRxiv and medRxiv, the world’s leading preprint servers for life and health sciences. openRxiv ensures that researchers worldwide can continue to share discoveries rapidly and openly. With a researcher-led governance model, openRxiv strengthens the foundation of preprint sharing, empowering scientists to…

Bluesky

End-of-year preprints - the genetics & genomics edition - preLights

Risk Factors of Human Mpox (Monkeypox) Infection: A Systematic Review and Meta-Analysis

Background: Mpox (formerly Monkeypox) virus has affected the lives of thousands of individuals both in endemic and non-endemic countries. Before the May 2022 outbreak, Mpox infections were sporadically endemic in Central and Western Africa, still research into Mpox has been limited and lacking epidemiological data. Thus, identification of potential risk factors to better understand who is at risk of being infected is critical for future prevention and control. Objective: To synthesize comprehensive evidence on risk factors associated with human Mpox transmission both in endemic and non-endemic countries from inception to March 31, 2024. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed in conducting the systematic review. Electronic databases were searched. Two reviewers sifted the articles that were included in the review: firstly, by title and abstract, and secondly, by full text. We used the Newcastle-Ottawa Scale (NOS) to assess the risk of bias for included articles. Fixed or random effects meta-analysis were conducted when at least two studies reported odds ratios (OR), relative risks (RR), with 95% confidence intervals (CI). Heterogeneity was assessed using the I^2 statistic and sensitivity analysis was also done. The study protocol has been registered under PROSPERO with ID: CRD42023459895. Results: 947 articles were identified from the database search and 31 articles were eligible to be included in the systematic review. The findings of the meta-analysis showed that interaction with infected animals (OR=5.61,95%CI=2.83,11.13), HIV (OR=4.46,95%CI=3.27,6.08), other STIs (OR=1.76,95%CI=1.42,2.91), sexual contact/activities (OR=1.53,95% CI=1.13,4.82), contact with an infected person (OR=2.39,95%CI=1.87,3.05), being identified as men who have sex with men (MSM) (OR=2.18,95%CI=1.88,2.51), and having multiple sexual partners Mpox (OR=1.61,95%CI=1.24,2.09), were associated with an increased risk of contracting Mpox. However, patients who were vaccinated against smallpox had a lower risk of Mpox infection (OR=0.24,95%CI=0.11,0.55). Conclusion: This study is the first meta-analysis on reported risk factors for Mpox. Our analysis demonstrated that certain factors were associated with increased risk of Mpox, whereas smallpox vaccination had a protective role against contracting Mpox. The study findings could facilitate future strategic public health planning and targeted intervention. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This research is funded by the Canadian Institute for Health Research (CIHR) under the Mpox and other601 zoonotic threats Team Grant (FRN. 187246). ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes All data produced in the present work are contained in the manuscript. Other information related to the present study are also available upon reasonable request to the authors.

Welcome to our user survey!

Take this survey powered by surveymonkey.com. Create your own surveys for free.